Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Physiol. 2019 May 22;597(12):3085–3105. doi: 10.1113/JP277856

Figure 4. CM4620 administration significantly reduces pancreatitis responses in mouse cerulein acute pancreatitis.

Figure 4.

Pancreatitis was induced in mice by supramaximal cerulein administration (50 μg/kg, 7 hourly IP injections); saline-treated mice were used as controls (−). CM4620 (20 mg/kg) or vehicle control were administered intraperitoneally 30 min before the 1st and 4th cerulein injection; blood and tissues were collected 1 h after the last cerulein injection. Graphs show levels of amylase (A) and lipase (B) in blood, and trypsin activity in pancreatic tissue homogenates. Data in graphs are mean ± SD of the values from of 3 mice per group.